Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration

Show simple item record

dc.contributor.author Sonigo, Charlotte
dc.contributor.author Bouilly, Justine
dc.contributor.author Carre, Nadège
dc.contributor.author Tolle, Virginie
dc.contributor.author Caraty, Alain
dc.contributor.author Tello, Javier A.
dc.contributor.author Simony-Conesa, Fabian-Jesus
dc.contributor.author Millar, Robert P.
dc.contributor.author Young, Jacques
dc.contributor.author Binart, Nadine
dc.date.accessioned 2012-11-28T07:16:41Z
dc.date.available 2012-11-28T07:16:41Z
dc.date.issued 2012-10
dc.description.abstract Hyperprolactinemia is the most common cause of hypogonadotropic anovulation and is one of the leading causes of infertility in women aged 25–34. Hyperprolactinemia has been proposed to block ovulation through inhibition of GnRH release. Kisspeptin neurons, which express prolactin receptors, were recently identified as major regulators of GnRH neurons. To mimic the human pathology of anovulation, we continuously infused female mice with prolactin. Our studies demonstrated that hyperprolactinemia in mice induced anovulation, reduced GnRH and gonadotropin secretion, and diminished kisspeptin expression. Kisspeptin administration restored gonadotropin secretion and ovarian cyclicity, suggesting that kisspeptin neurons play a major role in hyperprolactinemic anovulation. Our studies indicate that administration of kisspeptin may serve as an alternative therapeutic approach to restore the fertility of hyperprolactinemic women who are resistant or intolerant to dopamine agonists. en_US
dc.description.sponsorship R. Millar is recipient of a grant from the Medical Research Council (South Africa) and the University of Pretoria. en_US
dc.description.uri http://www.jci.org en_US
dc.identifier.citation Sonigo, C, Bouilly, J, Carre, N, Tolle, V, Caraty, A, Tello, J, Simony-Conesa, FJ, Millar, R, Young, J & Binart, N 2012, 'Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration', Journal of Clinical Investigation, vol. 122, no. 10, pp. 3791–3795, doi:10.1172/JCI63937. en_US
dc.identifier.issn 0021-9738 (print)
dc.identifier.issn 1558-8238 (online)
dc.identifier.other 10.1172/JCI63937
dc.identifier.uri http://hdl.handle.net/2263/20551
dc.language.iso en en_US
dc.publisher American Society for Clinical Investigation en_US
dc.rights American Society for Clinical Investigation en_US
dc.subject Hyperprolactinemia en_US
dc.subject Kisspeptin en_US
dc.title Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record